Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2000
03/23/2000CA2342290A1 Propagation and/or derivation of embryonic stem cells
03/23/2000CA2341781A1 Methods for producing genetically modified plants, plant materials and plant products produced thereby
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341304A1 Compositions and methods for the treatment of tumors
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000CA2341144A1 Recombinant vanadium haloperoxidases and their uses
03/23/2000CA2340586A1 T-type calcium channel
03/23/2000CA2340583A1 Plant resistance to insect pests mediated by viral proteins
03/23/2000CA2340332A1 Uracil permease from arabidopsis as herbicidal target gene
03/23/2000CA2337902A1 Maize replication protein a
03/23/2000CA2309762A1 Immune activation by double-stranded polynucleotides
03/22/2000EP0987329A2 Multimeric form of human rhinovirus receptor protein
03/22/2000EP0987325A1 Method for separating cells
03/22/2000EP0987324A2 Cell growth accelerator containing polyphosphoric acid and cell growth method using the same
03/22/2000EP0987034A2 Apparatus and method for isolating and recovering cells
03/22/2000EP0987029A1 Use of a catonic polymer for the preparation of a complex with nucleic acid and related compositions
03/22/2000EP0986652A1 Reagents and methods useful for detecting diseases of the urinary tract
03/22/2000EP0986651A1 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
03/22/2000EP0986649A1 Retroviral vector particles produced in a baculovirus expression system
03/22/2000EP0986647A1 FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES
03/22/2000EP0986646A1 Ubiquitin conjugation proteins
03/22/2000EP0986644A1 Production of erythropoietin by endogenous gene activation
03/22/2000EP0986643A1 Reagents and methods useful for detecting diseases of the breast
03/22/2000EP0986640A2 Transgenic fish with tissue-specific expression
03/22/2000EP0986639A1 Dna sequence coding for a mammalian glucuronyl c5-epimerase and a process for its production
03/22/2000EP0986637A2 Ribozymes cleaving epidermal growth factor receptors
03/22/2000EP0986636A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
03/22/2000EP0986635A1 Embryonic stem cell serum replacement
03/22/2000EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/22/2000EP0986533A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals
03/22/2000EP0986299A2 Plant transformation methods
03/22/2000EP0929809B1 Process and device for in vitro diagnosis of allergic disorders
03/22/2000EP0690874B1 Materials and methods relating to proteins that interact with casein kinase i
03/22/2000CN1248293A Sense intron inhibition of starch branching enzyme expression
03/22/2000CN1248291A Phosphodiesterase 8A
03/22/2000CN1248290A Method for induction of apoptotic cell death in malignant cells, through reduction of the RB to apoptosis inducing proteins ratio
03/22/2000CN1248289A Phosphate-deficiency inducible promoter
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1050668C Method for early detection of septicaemia and for treatment-accompanying assessment of course of sepsis, as well as means for carrying out said method
03/21/2000US6040437 A polypeptide having the ability to bind a tyrosine phosphatase which contains a noncatalytic domain; inducing polymerization of actin monomers in eukaryotic cells; antagonists, agonists
03/21/2000US6040431 Single chain analogs of the TGF-β superfamily (morphons)
03/21/2000US6040430 Nucleic acid encoding site specific recombinase and nuclear receptor fusion protein
03/21/2000US6040429 Congenital heart disease proteins and products related thereto
03/21/2000US6040180 Culturing of central nervous system stem cells in serum-free culture medium containing a growth factor, replacing with serum-free/growth factor-free medium, harvesting stem cells, plating, and culturing in serum-free/glutamic acid-free media
03/21/2000US6040177 Adding large number of non-dividing peripheral blood mononuclear cells as feeder cells to t-cells in culture medium, activating t-cell receptor complex, adding vector and incubating producing antigen-specific and restricted cells
03/21/2000US6040174 Defective adenoviruses and corresponding complementation lines
03/21/2000US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040159 Nucleotide sequence of ribonucleotides and optionally deoxyribonucleotides with optionally modified phosphates and hydrogen bonded to itself; targeted against tumor necrosis factor; for antiarthritic agents, antisense agents, viricides
03/21/2000US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects
03/21/2000US6040139 Laser cell purification system
03/21/2000US6040136 Phagemid expression vector having a transcription regulatory sequence linked to gene encoding a fusion protein of a polypeptide and a bacteriophage coat protein; for library of proteins expressed in low quantity on particle surface
03/21/2000US6039760 Composite living skin equivalent
03/16/2000WO2000014261A1 Production of human erythropoietin
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014249A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000WO2000014246A1 Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof
03/16/2000WO2000014242A1 Novel protein, gene encoding the same and utilization thereof
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014221A1 Glycine transporter
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000WO2000014213A1 Highly efficient mutagenesis method with the use of psoralen derivatives
03/16/2000WO2000014212A1 Novel protein kinase molecules and uses therefor
03/16/2000WO2000014209A1 Endothelial cell proliferation inhibitors derived from human prothrombin
03/16/2000WO2000014206A2 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000WO2000014205A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors
03/16/2000WO2000014203A1 Method for preparing cell fraction containing hematopoietic stem cells
03/16/2000WO2000014202A1 Methods for generating doubled haploid plants
03/16/2000WO2000014200A2 Essential bacterial genes and their use
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000013651A2 Luciferase reporter bioassay of parathyroid hormone compounds
03/16/2000WO2000006704A3 Hematopoietic cell composition for use in transplantation
03/16/2000WO2000003029A3 Chimaeric adenoviruses
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter
03/16/2000WO2000000500A3 Polyketides and their synthesis
03/16/2000WO1999067391A9 Origin of replication and methods of use
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000WO1999065937A9 Truncated apaf-1 and methods of use thereof
03/16/2000WO1999064598A3 Novel insulin analogs with enhanced zinc binding
03/16/2000WO1999064579A9 Corn oleosin promoter and genes encoding corn desaturases
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
03/16/2000WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
03/16/2000WO1999055906A3 Gene screening methods and related assays
03/16/2000WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
03/16/2000WO1999036516A3 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
03/16/2000DE19841125A1 Positioning living cells within a 3-dimensional microstructure with movement-limiting openings, especially useful for study by atomic force microscopy
03/16/2000DE19830907A1 Verfahren zur Optimierung der Produktion von Adenovirus-Vektoren A method for optimizing the production of adenovirus vectors
03/16/2000CA2343351A1 Human transferase proteins
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342983A1 Methods for generating doubled haploid plants
03/16/2000CA2342859A1 Production of human erythropoietin
1 ... 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 ... 1827